摘要
目的:为完善中国国家基本药物制度提供政策建议和科学参考。方法:综述中国国家基本药物制度建立以来取得的成效和存在的问题,理论上探讨基本药物的公共产品属性。结果:基本药物制度实施以来,围绕制度构成因素出台了相应的配套政策,药品费用下降、质量提高、合理用药情况好转,但目录药品遴选不够科学,药品招标难以带量采购,基本药物报销受制于国家现有三大基本医疗保障制度,基层医疗机构综合改革对基本药物制度建设形成阻力,使得基本药物尚未能达到公平可及、人人获得的目标。结论:中国国家基本药物制度能够真正促进药品公平可及,需要建立基本药物供应保障预算基金,并使各组成要素与之有效衔接,逐步完善基本药物公平供应保障体制。
Objective： To provide policy suggestions and scientific references for improving the national essential medicine policy （NEMP） in China. Methods： The accomplishments made since the establishment of NEMP and existing problems were summarized and the public attributes of essential medicines were analyzed theoretically. Results： Since the establishment ofNEMP, the policies related to the system elements have been worked out, expenses on drugs decreased, drug quality and rational drug use have been improved. However, the essential medicine selection was not done in a scientific way, it is hard to carry out drug bid procurement in quantity, the reimbursement of essential medicines was subjected to the existing national basic medical insurance system, and the overall reform of the basic medical and health institutions dragged the construction of NEMP. For the above reasons, the goal of equitable access to essential medicines for all has not been achieved. Conclusion： To achieve the goal of access to essential medicines for all, a budget fund to guarantee the supply of essential medicines should be established and the composition elements should function effectively to match the budget fund, and the supply security system of essential medicines needs to be improved.
出处
《中国执业药师》
CAS
2013年第5期83-87,共5页
China Licensed Pharmacist
关键词
基本药物
可及性
筹资机制
Essential Medicine
Accessibility
Financing Mechanism
